Innovate Vs. Nektar Therapeutics Industry Stock Comparison

Sell

26

VATE
Innovate

Last Price:

$5.86

Seasonality Move:

-13.9%

Sell

49

NKTR
Nektar Therapeutics

Last Price:

$24.57

Seasonality Move:

2.04%

Sell

26

Innovate (VATE) is a Sell

Is Innovate a Buy, Sell or Hold?

The current Innovate [VATE] share price is $5.26. The Score for VATE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
VATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

49

Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

The current Nektar Therapeutics [NKTR] share price is $24.14. The Score for NKTR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VATE Stock Price Chart

What is Innovate's stock price today?

The Innovate share price today is $5.26

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VATE is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

The Nektar Therapeutics share price today is $24.14

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.

VATE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.47	Buy
Relative Strength Index (14 RSI):	43.79	Sell
Chaikin Money Flow:	-654	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.24 - 5.52)	Sell
Bollinger Bands (100):	(5.18 - 8.18)	Sell

NKTR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	6.61	Buy
Relative Strength Index (14 RSI):	62.41	Buy
Chaikin Money Flow:	356028	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11.6 - 27.18)	Buy
Bollinger Bands (100):	(7.48 - 18.56)	Buy

VATE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.45	Sell
20-day SMA:	5.36	Sell
50-day SMA:	5.77	Sell
200-day SMA:	6.55	Sell
8-day EMA:	4.48	Buy
20-day EMA:	2.74	Buy
50-day EMA:	1.33	Buy
200-day EMA:	0.37	Buy

NKTR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	24	Buy
20-day SMA:	21.86	Buy
50-day SMA:	14.8	Buy
200-day SMA:	14.65	Buy
8-day EMA:	20.01	Buy
20-day EMA:	12.16	Buy
50-day EMA:	5.89	Buy
200-day EMA:	1.63	Buy

Innovate Earnings Growth & VATE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.

Innovate Technical Analysis

	Jul 2	Jul 3	Jul 7	Jul 8	Jul 9	Jul 10	Jul 11	Jul 14	Jul 15	Jul 16
	Jul
	02	03	07	08	09	10	11	14	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

	Jul 2	Jul 3	Jul 7	Jul 8	Jul 9	Jul 10	Jul 11	Jul 14	Jul 15	Jul 16
	Jul
	02	03	07	08	09	10	11	14	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):